Showing results (21-30 of 267) with videos related to
Sort By:
Pageof 27
Prostaglandins & Other Lipid Mediators|December 14, 2006
The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligandsJamie J O'Brien, Denise M Ray, Sherry L Spinelli, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2009
Foxp3 regulates megakaryopoiesis and platelet functionJamie J Bernard, Kathryn E Seweryniak, Anne D Koniski, et al.Cellular Immunology|October 5, 2010
Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activationSimona Bancos, Richard P PhippsAmerican Journal of Physiology. Cell Physiology|July 11, 2002
Differential COX localization and PG release in Thy-1(+) and Thy-1(-) human female reproductive tract fibroblastsLaura Koumas, Richard P PhippsTransfusion Medicine Reviews|May 15, 2017
Management of Platelet Disorders and Platelet Transfusions in ICU PatientsNeil Blumberg, Jill M Cholette, Amy E Schmidt, et al.Thrombosis and Haemostasis|January 25, 2008
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticlesDenise M Ray, Sherry L Spinelli, Stephen J Pollock, et al.Blood|August 30, 2008
15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytesJamie J O'Brien, Sherry L Spinelli, Joanna Tober, et al.Immunology|February 19, 2002
Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cellsSarah G Harris, Richard P PhippsImmunology|January 6, 2010
Inhibition of cyclooxygenase-2 impairs the expression of essential plasma cell transcription factors and human B-lymphocyte differentiationMatthew P Bernard, Richard P PhippsClinical Immunology (Orlando, Fla.)|August 31, 2007
CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody productionMatthew P Bernard, Richard P PhippsPageof 27